Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Human cell-mediated cytotoxicity against modified target cells is restricted by HLA

Abstract

T-CELL-mediated lysis of virus-infected target cells in mice is restricted by the H–2D and H–2K antigens of the major histocompatibility complex (MHC) in the sense that the cytotoxic T cells are only active against virus-infected target cells sharing H–2D and/or H–2K antigens with the animal in which the killer cells have been raised1. These findings led to a better understanding of the way in which the MHC regulates certain functions of the immune system2, and they have been amply confirmed by further studies in inbred strains of mice and guinea pig which have indicated that restriction by antigens of the MHC is a general phenomenon in the T-cell-mediated immune response3 in these species. Evidence for MHC restriction of the immune response in man, however, was lacking until it was shown that a female patient who had rejected a bone marrow graft from her HLA-identical brother, had cytotoxic cells in her blood, and that the activity of these cells was restricted to male target cells which had the HLA-A2 antigen in common with herself4. We show here in a more general way, that the cell-mediated cytotoxicity which can be raised in humans against ‘altered self’ is restricted by the HLA-A, B and C antigens.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Zinkernagel, R. M. & Doherty, P. R. Nature 248, 701–702 (1974).

    Article  ADS  CAS  Google Scholar 

  2. Doherty, P. C. & Zinkernagel, R. M. Lancet i, 1406–1409 (1975).

    Article  Google Scholar 

  3. Miller, J. A. F. P., Vadas, M. A., Whitelaw, A. & Gamble, J. Proc. natn. Acad. Sci, U.S.A. 73, 2486–2490 (1976).

    Article  ADS  CAS  Google Scholar 

  4. Goulmy, E., Termijtelen, A., Bradley, B. A. & van Rood, J. J. Nature 266, 544–545 (1977).

    Article  ADS  CAS  Google Scholar 

  5. Søeberg, B. & Anderson, V. Clin. exp. Immun. 25, 490–492 (1976).

    Google Scholar 

  6. Simpson, E. & Gordon, R. D. Immun. Rev. 35, 59–75 (1977).

    Article  CAS  Google Scholar 

  7. Zinkernagel, R. M., Dunlop, M. B. C., Blanden, R. V., Doherty, P. C. & Shreffler, D. C. J. exp. Med. 144, 519–532 (1976).

    Article  CAS  Google Scholar 

  8. Bubbers, J. E., Blank, K. J., Freedman, H. A. & Lilly, F. Scand. J. Immun. 6, 533–539 (1977).

    Article  CAS  Google Scholar 

  9. Trinchieri, G., Bernoco, D., Curtoni, S. E., Miggiano, V. C. & Ceppellini, R. in Histocompatibility Testing 1972, 510–519 (Munksgaard, Copenhagen, 1973).

    Google Scholar 

  10. Simonsen, M. Transplant. Rev. 3, 22–35 (1970).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

DICKMEISS, E., SOEBERG, B. & SVEJGAARD, A. Human cell-mediated cytotoxicity against modified target cells is restricted by HLA. Nature 270, 526–528 (1977). https://doi.org/10.1038/270526a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/270526a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing